No shortage of antiretroviral drugs in India: Health Ministry

Subject :Polity

Section: National body

Context:

There is adequate stock for around 95% ‘People Living with HIV’, Health Ministry clarifies
1st & 2nd line antiretroviral drugs ARV regimens like Tablet TLD (Tenofovir+ Lamivudine+ Dolutegravir) and other ARV regimens.
India is one of the very few countries that provides free anti-retroviral medicines for life-long treatment of more than 14.5 lakh PLHIV through 680 antiretroviral therapy (ART) centres under its National AIDS Control Programme (NACP), which is fully funded by the Government of India.
Tablet Dolutegravir (DTG)-50mg is required for around 50,000 PLHIV who are either on Alternate-1st/2nd or 3rd-line regimens, or those with TB co-infection
National strategic plan (2017-24) and Mission SAMPARK
- The Ministry of Health and Family Welfare has launched the plan with aim to eradicating HIV/AIDS by 2030. It is expected to pave a roadmap for achieving the target of 90:90:90.

Target of 90:90:90-

By 2020, 90% of all people living with HIV will know their HIV status.
By 2020, 90% of all people with diagnosed HIV infection will receive sustained antiretroviral therapy.
By 2020, 90% of all people receiving antiretroviral therapy will have viral suppression.
Mission ‘SAMPARK’ aimed at tracing those who are HIV positive and are to be brought under antiretroviral therapy (ART) services
The Global Fund for AIDS TB and Malaria (GFTAM)
- Recently, India has announced a contribution of $22 million to the Global Fund for AIDS, TB and Malaria (GFTAM) for the 6th replenishment cycle (2020-22). The Global Fund is a partnership designed to accelerate the end of AIDS, tuberculosis and malaria.
- As an international organization, the Global Fund mobilizes and invests more than $4 billion a year to support programs run by local experts in more than 100 countries.